During the past decade, Mercy Health System conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 15 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Health System" #1 sponsor was "SWOG Cancer Research Network" with 10 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "University of Wisconsin, Madison" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Health System" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Health System" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Breast Cancer" (3 trials), "Pain" (2 trials) and "Stage IIIA Breast Cancer" (2 trials). Many other conditions were trialed in "Mercy Health System" in a lesser frequency.

Most popular intervention types in "Mercy Health System" are "Drug" (19 trials), "Other" (14 trials), "Biological" (6 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (3 trials), "Paclitaxel" (3 trials), "Quality-of-Life Assessment" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Health System" are 18 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Health System". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Mercy Health System, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Health System, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Mercy Health System has several departments that took part in Clinical trials: "Mercyhealth Hospital and Cancer Center - Janesville" - 49 trials